Kyowa Kirin Subsidiary ProStrakan To Buy Archimedes for JPY39.9Bn
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin’s UK subsidiary ProStrakan is to acquire Archimedes Pharma UK, a UK-based company specializing in pain, cancer, and critical care for GBP230 million, or roughly JPY39.9 billion, the Japanese company announced on July 11.